5-150848653-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001145805.2(IRGM):c.530G>A(p.Arg177Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000045 in 1,533,116 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001145805.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IRGM | NM_001145805.2 | c.530G>A | p.Arg177Gln | missense_variant | 2/2 | ENST00000522154.2 | |
IRGM | NM_001346557.2 | c.530G>A | p.Arg177Gln | missense_variant, splice_region_variant | 2/4 | ||
IRGM | NR_170598.1 | n.1645G>A | splice_region_variant, non_coding_transcript_exon_variant | 2/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IRGM | ENST00000522154.2 | c.530G>A | p.Arg177Gln | missense_variant | 2/2 | 1 | NM_001145805.2 | P1 | |
IRGM | ENST00000520549.1 | c.158G>A | p.Arg53Gln | missense_variant, splice_region_variant, NMD_transcript_variant | 1/4 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152130Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000977 AC: 14AN: 143348Hom.: 0 AF XY: 0.0000656 AC XY: 5AN XY: 76220
GnomAD4 exome AF: 0.0000463 AC: 64AN: 1380868Hom.: 1 Cov.: 30 AF XY: 0.0000383 AC XY: 26AN XY: 678714
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152248Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74436
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 18, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at